Scopus BioPharma Inc.
SCPS · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $5 |
| - Cash | $0 | $1 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $0 | $2 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$3 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.066 | -0.081 | -0.082 | -0.09 |
| % Growth | 18.5% | 1.7% | 8.8% | – |
| Operating Cash Flow | -$1 | -$1 | -$0 | -$1 |
| Capital Expenditures | $0 | $0 | -$2 | $0 |
| Free Cash Flow | -$1 | -$1 | -$2 | -$1 |